Sunhawk Vision Biotech, Inc. (TPEX: 7759)
Health Care · Pharmaceuticals · TW
NT$29.40
-1.01% today · -57.6% 1Y
Sunhawk Vision Biotech, Inc. (TPEX: 7759) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $64.38M.
Over the last twelve months the share price has lost 57.6%, trading between 25.60 and 83.60.
Tweenvest scores Sunhawk Vision Biotech, Inc. across four factors: quality 28/100. Its strongest factor is quality.
7759 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $64.38M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -2.47
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- NT$83.60
- 52-week low
- NT$25.60
- Avg volume (3M)
- —
- Shares outstanding
- 70.07M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,190.02 | -3.54% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.56 | -0.94% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.39 | -1.96% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.39 | -0.65% |
Figures last refreshed Aug 18, 2026.